Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Philipp Schuldt"'
Autor:
Florian Malchers, Lucia Nogova, Martijn H.A. van Attekum, Lukas Maas, Johannes Brägelmann, Christoph Bartenhagen, Luc Girard, Graziella Bosco, Ilona Dahmen, Sebastian Michels, Clare E. Weeden, Andreas H. Scheel, Lydia Meder, Kristina Golfmann, Philipp Schuldt, Janna Siemanowski, Jan Rehker, Sabine Merkelbach-Bruse, Roopika Menon, Oliver Gautschi, Johannes M. Heuckmann, Elisabeth Brambilla, Marie-Liesse Asselin-Labat, Thorsten Persigehl, John D. Minna, Henning Walczak, Roland T. Ullrich, Matthias Fischer, Hans Christian Reinhardt, Jürgen Wolf, Reinhard Büttner, Martin Peifer, Julie George, Roman K. Thomas
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 21 (2023)
The discovery of frequent 8p11-p12 amplifications in squamous cell lung cancer (SQLC) has fueled hopes that FGFR1, located inside this amplicon, might be a therapeutic target. In a clinical trial, only 11% of patients with 8p11 amplification (detecte
Externí odkaz:
https://doaj.org/article/ef6247e9f6b84dbca5a0844486ed3d80
Autor:
Roland T. Ullrich, H. Christian Reinhardt, Michael von Bergwelt-Baildon, Marco Herling, Michael Hallek, Juergen Wolf, Reinhard Buettner, Margarete Odenthal, Hans A. Schlößer, Kristina Golfmann, Alexandra Florin, Richard Riedel, Sebastian Oberbeck, Ignacija Vlasic, Kerstin Wennhold, Sven Borchmann, Sebastian Klein, Felix Dietlein, Anna Schmitt, Martin Thelen, Philipp Schuldt, Lydia Meder
Clinicopathologic parameters of mice and patients with the corresponding survival significance analysis of SCLC bearing mice treated with vehicle, IgG control, anti-VEGF monotherapy, anti-PD-L1 monotherapy or anti-VEGF/anti-PD-L1 combination therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6088b8867cd54654f9e0a65a7afd339c
https://doi.org/10.1158/0008-5472.22411914.v1
https://doi.org/10.1158/0008-5472.22411914.v1
Autor:
Roland T. Ullrich, H. Christian Reinhardt, Michael von Bergwelt-Baildon, Marco Herling, Michael Hallek, Juergen Wolf, Reinhard Buettner, Margarete Odenthal, Hans A. Schlößer, Kristina Golfmann, Alexandra Florin, Richard Riedel, Sebastian Oberbeck, Ignacija Vlasic, Kerstin Wennhold, Sven Borchmann, Sebastian Klein, Felix Dietlein, Anna Schmitt, Martin Thelen, Philipp Schuldt, Lydia Meder
Small cell lung cancer (SCLC) represents the most aggressive pulmonary neoplasm and is often diagnosed at late stage with limited survival, despite combined chemotherapies. We show in an autochthonous mouse model of SCLC that combined anti-VEGF/anti-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a76e028cb5f9939e2f17930f313732bb
https://doi.org/10.1158/0008-5472.c.6508329.v1
https://doi.org/10.1158/0008-5472.c.6508329.v1
Autor:
Roland T. Ullrich, H. Christian Reinhardt, Michael von Bergwelt-Baildon, Marco Herling, Michael Hallek, Juergen Wolf, Reinhard Buettner, Margarete Odenthal, Hans A. Schlößer, Kristina Golfmann, Alexandra Florin, Richard Riedel, Sebastian Oberbeck, Ignacija Vlasic, Kerstin Wennhold, Sven Borchmann, Sebastian Klein, Felix Dietlein, Anna Schmitt, Martin Thelen, Philipp Schuldt, Lydia Meder
Supplementary data supporting an exhausted T cell phenotype in SCLC upon acquired resistance to PD1/PD-L1 blockade which is regulated by VEGF/VEGFR signaling and in addition, an immunosuppressive role of tumor-associated macrophages in the tumor micr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e6ebdbe4c2b9b6d834aa5794cc91d33
https://doi.org/10.1158/0008-5472.22411920.v1
https://doi.org/10.1158/0008-5472.22411920.v1
Autor:
Sebastian Oberbeck, Juergen Wolf, Reinhard Buettner, H. Christian Reinhardt, Michael von Bergwelt-Baildon, Hans A. Schlößer, Alexandra Florin, Sven Borchmann, Michael Hallek, Margarete Odenthal, Ignacija Vlasic, Roland T. Ullrich, R. Riedel, Marco Herling, Kerstin Wennhold, Felix Dietlein, Anna Schmitt, Martin Thelen, Philipp Schuldt, Kristina Golfmann, Sebastian Klein, Lydia Meder
Small cell lung cancer (SCLC) represents the most aggressive pulmonary neoplasm and is often diagnosed at late stage with limited survival, despite combined chemotherapies. We show in an autochthonous mouse model of SCLC that combined anti-VEGF/anti-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::995153c466b400d9a07c8f8327ef7587
https://www.bib.irb.hr/951691
https://www.bib.irb.hr/951691